If you are looking for a prescription medicine to treat ADHD, you might be considering Elvanse. This medication is approved for use in patients aged six years and older. Its patented prodrug technology makes it possible for the medicine to remain active in the body for several months. In addition, its capsules are not crushable or mechanically manipulated to release the active ingredient d-AMF. This makes it much harder for people to misuse the medication.
VYVANSE is used to treat attention deficit hyperactivity disorder (ADHD) in patients ages six to 17 years. The study involved 276 pediatric patients with DSM-IV criteria for ADHD. Of these, two-thirds were enrolled directly into the study. Participants in Study 5 were treated with open-label VYVANSE for 26 weeks. In order to be considered a response, patients were required to show improvement on the CGI-S and Total Score of the ADHD-RS.
The study was a placebo-controlled, multicentre phase three trial, which was presented at the European College of Neuropsychopharmacology congress in Vienna on October 13th, 2012. It is important to note that stimulants can be addictive and have a high risk of diversion and abuse. Therefore, it is important to monitor the drug closely and work with a licensed psychiatrist. A comprehensive study assessing the use of Elvanse for ADHD in children is needed.
The study showed that VYVANSE had a greater effect than placebo. A standardized clinical global impression-I score of the patient’s ADHD symptoms (impulsivity and hyperactivity) was 19.7 points lower than placebo in the group that received VYVANSE. Overall, the study demonstrated that Elvanse was an effective treatment for ADHD. This drug has been approved for use in children as young as six years of age. It can be used for adults as well.
Write Reviews
Leave a Comment
No Comments & Reviews